WM: 2023 update on diagnosis, risk stratification, and management

Gertz MA

Am J Hematol · 2023

Grade Bnarrative reviewUnverified

Key Findings

  • ●Comprehensive annual update on WM management
  • ●Updated treatment algorithms incorporating BTK inhibitors
  • ●Discussion of emerging agents and combination strategies

Referenced in (1 disease)

Validation history

Full log →

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.

ID: pmid-36588395DOI: 10.1002/ajh.26796PMID: 36588395